Analyst
CWC
Equibles does not estimate personal net worth.
Siddharth Neghandi is recorded as Analyst at CWC. Siddharth Neghandi has spoken on 1 earnings call across 1 company, most recently for Emcure Pharmaceuticals Limited on May 5, 2026. The companies whose calls Siddharth Neghandi spoke on are classified in the Healthcare sector.
“You had recently licensed these Nefro brands from Roche. Could you give a sense of what is the annual revenue run rate for those brands and also what sort of upfront payment have you made?”
CWC
Analyst
Transcript header (unverified)
Emcure Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Emcure Pharmaceuticals Limited
